China Traditional Chinese Medicine Holdings Co., often referred to as China TCM, is a prominent player in the traditional Chinese medicine industry, headquartered in China (CN). Established in 2001, the company has made significant strides in promoting the benefits of traditional herbal remedies and therapies across major operational regions, including Asia and beyond. Specialising in the research, development, and distribution of traditional Chinese medicinal products, China TCM offers a unique range of herbal formulations and health supplements that are rooted in centuries-old practices. The company is recognised for its commitment to quality and innovation, ensuring that its products meet rigorous health standards. With a strong market position, China TCM has achieved notable milestones, including strategic partnerships and a growing international presence, solidifying its reputation as a leader in the traditional medicine sector.
How does China Traditional Chinese Medicine Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
China Traditional Chinese Medicine Holdings Co's score of 23 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, China Traditional Chinese Medicine Holdings Co reported total carbon emissions of approximately 338,793,600 kg CO2e. This figure includes about 106,562,200 kg CO2e from Scope 1 emissions and approximately 232,231,400 kg CO2e from Scope 2 emissions. The company has shown a commitment to addressing its carbon footprint, although no specific reduction targets or initiatives have been disclosed. Looking at previous years, emissions in 2022 were about 377,850,700 kg CO2e, with Scope 1 and Scope 2 emissions of approximately 122,799,100 kg CO2e and 255,051,600 kg CO2e, respectively. In 2021, the total emissions were similar at around 306,697,800 kg CO2e, with Scope 1 emissions of about 105,687,600 kg CO2e and Scope 2 emissions of approximately 201,010,200 kg CO2e. The company has not publicly committed to any specific science-based targets or reduction initiatives, indicating a potential area for improvement in its climate strategy. As the industry increasingly prioritises sustainability, China Traditional Chinese Medicine Holdings Co may need to enhance its climate commitments to align with global standards.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 28,940,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 16,058,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | 000,000,000 | 000,000,000 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Traditional Chinese Medicine Holdings Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.